Published in Proc Natl Acad Sci U S A on August 10, 2012
Sclerostin alters serum vitamin D metabolite and fibroblast growth factor 23 concentrations and the urinary excretion of calcium. Proc Natl Acad Sci U S A (2013) 1.70
HDAC5 controls MEF2C-driven sclerostin expression in osteocytes. J Bone Miner Res (2015) 1.60
Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH. J Biol Chem (2013) 1.23
Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches. Nat Rev Endocrinol (2013) 1.23
A Comprehensive Overview of Skeletal Phenotypes Associated with Alterations in Wnt/β-catenin Signaling in Humans and Mice. Bone Res (2013) 0.94
Sclerostin Inhibition in the Management of Osteoporosis. Calcif Tissue Int (2016) 0.92
Removal of SOST or blocking its product sclerostin rescues defects in the periodontitis mouse model. FASEB J (2015) 0.92
Functional anatomy of distant-acting mammalian enhancers. Philos Trans R Soc Lond B Biol Sci (2013) 0.91
Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles? Osteoporos Int (2014) 0.90
Sost and its paralog Sostdc1 coordinate digit number in a Gli3-dependent manner. Dev Biol (2013) 0.89
Sclerostin antibody treatment improves fracture outcomes in a Type I diabetic mouse model. Bone (2015) 0.84
Regulation of bone metabolism by Wnt signals. J Biochem (2015) 0.83
A mobile insulator system to detect and disrupt cis-regulatory landscapes in vertebrates. Genome Res (2013) 0.80
The osteocyte plays multiple roles in bone remodeling and mineral homeostasis. Med Mol Morphol (2015) 0.79
Developments in sclerostin biology: regulation of gene expression, mechanisms of action, and physiological functions. Curr Osteoporos Rep (2014) 0.79
Role and mechanism of action of sclerostin in bone. Bone (2016) 0.78
Analysis of association of MEF2C, SOST and JAG1 genes with bone mineral density in Mexican-Mestizo postmenopausal women. BMC Musculoskelet Disord (2014) 0.78
Lipoprotein receptor-related protein 6 is required for parathyroid hormone-induced Sost suppression. Ann N Y Acad Sci (2015) 0.77
Analysis of SOST expression using large minigenes reveals the MEF2C binding site in the evolutionarily conserved region (ECR5) enhancer mediates forskolin, but not 1,25-dihydroxyvitamin D3 or TGFβ1 responsiveness. J Steroid Biochem Mol Biol (2015) 0.77
Treatment with intermittent PTH increases Wnt10b production by T cells in osteoporotic patients. Osteoporos Int (2015) 0.77
SOST Inhibits Prostate Cancer Invasion. PLoS One (2015) 0.76
Osteogenesis induced by frizzled-related protein (FRZB) is linked to the netrin-like domain. Lab Invest (2016) 0.76
From disease to treatment: from rare skeletal disorders to treatments for osteoporosis. Endocrine (2016) 0.76
Computational Characterization of Osteoporosis Associated SNPs and Genes Identified by Genome-Wide Association Studies. PLoS One (2016) 0.75
Cancer-Osteoblast Interaction Reduces Sost Expression in Osteoblasts and Up-Regulates lncRNA MALAT1 in Prostate Cancer. Microarrays (Basel) (2015) 0.75
Sost, ECR5, Mef2C and van Buchem disease. Bonekey Rep (2012) 0.75
Interrogating transcriptional regulatory sequences in Tol2-mediated Xenopus transgenics. PLoS One (2013) 0.75
MMP-13 is one of the critical mediators of the effect of HDAC4 deletion on the skeleton. Bone (2016) 0.75
Mice with sclerostin gene deletion are resistant to the severe sublesional bone loss induced by spinal cord injury. Osteoporos Int (2016) 0.75
Multiple modes of Lrp4 function in modulation of Wnt/β-catenin signaling during tooth development. Development (2017) 0.75
The Microdamage and Expression of Sclerostin in Peri-implant Bone under One-time Shock Force Generated by Impact. Sci Rep (2017) 0.75
A new logic for DNA engineering using recombination in Escherichia coli. Nat Genet (1998) 15.27
Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc Natl Acad Sci U S A (1996) 12.92
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell (2001) 11.99
In vivo enhancer analysis of human conserved non-coding sequences. Nature (2006) 10.60
High-throughput engineering of the mouse genome coupled with high-resolution expression analysis. Nat Biotechnol (2003) 7.47
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet (2001) 5.72
Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science (1997) 5.54
Lrp5 functions in bone to regulate bone mass. Nat Med (2011) 5.33
Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet (2001) 4.97
Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res (2008) 4.82
MEF2: a central regulator of diverse developmental programs. Development (2007) 4.70
Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J (2003) 4.32
The univector plasmid-fusion system, a method for rapid construction of recombinant DNA without restriction enzymes. Curr Biol (1998) 4.14
Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease. J Med Genet (2002) 4.00
High bone mass in mice expressing a mutant LRP5 gene. J Bone Miner Res (2003) 3.48
DMP1-targeted Cre expression in odontoblasts and osteocytes. J Dent Res (2007) 3.07
MEF2C transcription factor controls chondrocyte hypertrophy and bone development. Dev Cell (2007) 2.96
Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. Am J Hum Genet (2003) 2.86
Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease. Genome Res (2005) 2.61
Dentin matrix protein 1 expression during osteoblastic differentiation, generation of an osteocyte GFP-transgene. Bone (2004) 2.35
Efficient and precise engineering of a 200 kb beta-globin human/bacterial artificial chromosome in E. coli DH10B using an inducible homologous recombination system. Gene Ther (1999) 2.32
A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population. Am J Med Genet (2002) 2.21
Parathyroid hormone (PTH)-induced bone gain is blunted in SOST overexpressing and deficient mice. J Bone Miner Res (2010) 2.19
Expression and activity of osteoblast-targeted Cre recombinase transgenes in murine skeletal tissues. Int J Dev Biol (2004) 2.15
Bone mineral density in sclerosteosis; affected individuals and gene carriers. J Clin Endocrinol Metab (2005) 2.05
Activation of receptor activator of NF-kappaB ligand gene expression by 1,25-dihydroxyvitamin D3 is mediated through multiple long-range enhancers. Mol Cell Biol (2006) 1.92
Control of the SOST bone enhancer by PTH using MEF2 transcription factors. J Bone Miner Res (2007) 1.74
Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones. J Bone Miner Res (2011) 1.70
Mef2c deletion in osteocytes results in increased bone mass. J Bone Miner Res (2012) 1.68
Targeted deletion of a distant transcriptional enhancer of the receptor activator of nuclear factor-kappaB ligand gene reduces bone remodeling and increases bone mass. Endocrinology (2007) 1.47
Upstream regulatory elements necessary for expression of the rat COL1A1 promoter in transgenic mice. J Bone Miner Res (1994) 1.24
Changes in cortical bone response to high-fat diet from adolescence to adulthood in mice. Osteoporos Int (2010) 1.00
Genetic evidence that SOST inhibits WNT signaling in the limb. Dev Biol (2010) 0.98
TGF-β regulates sclerostin expression via the ECR5 enhancer. Bone (2011) 0.94
Lrp5 and bone formation : A serotonin-dependent pathway. Ann N Y Acad Sci (2010) 0.93
Collagen1alpha1 promoter drives the expression of Cre recombinase in osteoblasts of transgenic mice. J Genet Genomics (2008) 0.85
Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med (2006) 10.95
High-throughput engineering of the mouse genome coupled with high-resolution expression analysis. Nat Biotechnol (2003) 7.47
The genome of the Western clawed frog Xenopus tropicalis. Science (2010) 4.70
ECR Browser: a tool for visualizing and accessing data from comparisons of multiple vertebrate genomes. Nucleic Acids Res (2004) 4.53
zPicture: dynamic alignment and visualization tool for analyzing conservation profiles. Genome Res (2004) 4.26
Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial. Arthritis Rheum (2008) 4.02
Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev (2003) 3.85
Convergent extension: the molecular control of polarized cell movement during embryonic development. Dev Cell (2002) 3.81
Structural basis of BMP signalling inhibition by the cystine knot protein Noggin. Nature (2002) 3.67
Thiazolidinedione use and bone loss in older diabetic adults. J Clin Endocrinol Metab (2006) 3.15
Wnt signaling gradients establish planar cell polarity by inducing Vangl2 phosphorylation through Ror2. Dev Cell (2011) 3.12
Evolution and functional classification of vertebrate gene deserts. Genome Res (2004) 2.92
Mulan: multiple-sequence local alignment and visualization for studying function and evolution. Genome Res (2004) 2.91
Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass. Nat Med (2012) 2.80
Predicting tissue-specific enhancers in the human genome. Genome Res (2007) 2.72
Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy. Mol Cell Biol (2004) 2.58
Neural tube closure requires Dishevelled-dependent convergent extension of the midline. Development (2002) 2.52
Shroom induces apical constriction and is required for hingepoint formation during neural tube closure. Curr Biol (2003) 2.49
Large-scale analysis of association between GDF5 and FRZB variants and osteoarthritis of the hip, knee, and hand. Arthritis Rheum (2009) 2.47
Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreERT2. J Immunol (2009) 2.44
Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice. J Bone Miner Res (2005) 2.41
The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial. Arthritis Rheum (2008) 2.37
Techniques and probes for the study of Xenopus tropicalis development. Dev Dyn (2002) 2.34
Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterning. Nat Genet (2003) 2.31
Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors. Genes Dev (2010) 2.28
Parathyroid hormone (PTH)-induced bone gain is blunted in SOST overexpressing and deficient mice. J Bone Miner Res (2010) 2.19
Absence of sclerostin adversely affects B-cell survival. J Bone Miner Res (2012) 2.18
Steroid-resistant kaposiform hemangioendothelioma: a retrospective study of 37 patients treated with vincristine and long-term follow-up. Pediatr Blood Cancer (2014) 2.14
The BMP antagonist noggin regulates cranial suture fusion. Nature (2003) 2.09
A genome-wide association study identifies an osteoarthritis susceptibility locus on chromosome 7q22. Arthritis Rheum (2010) 2.02
CREME: Cis-Regulatory Module Explorer for the human genome. Nucleic Acids Res (2004) 1.96
Efficient targeted gene disruption in the soma and germ line of the frog Xenopus tropicalis using engineered zinc-finger nucleases. Proc Natl Acad Sci U S A (2011) 1.90
Genetic evidence points to an osteocalcin-independent influence of osteoblasts on energy metabolism. J Bone Miner Res (2011) 1.89
Wntless functions in mature osteoblasts to regulate bone mass. Proc Natl Acad Sci U S A (2012) 1.85
Developmental anomalies of the cervical spine in patients with fibrodysplasia ossificans progressiva are distinctly different from those in patients with Klippel-Feil syndrome: clues from the BMP signaling pathway. Spine (Phila Pa 1976) (2005) 1.81
Osteocytes as mechanosensors in the inhibition of bone resorption due to mechanical loading. Bone (2007) 1.79
Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease. Am J Physiol Renal Physiol (2010) 1.78
Control of the SOST bone enhancer by PTH using MEF2 transcription factors. J Bone Miner Res (2007) 1.74
Depletion of three BMP antagonists from Spemann's organizer leads to a catastrophic loss of dorsal structures. Dev Cell (2005) 1.72
Acid-suppressive medications and risk of bone loss and fracture in older adults. Calcif Tissue Int (2008) 1.71
The aminobisphosphonate risedronate preserves localized mineral and material properties of bone in the presence of glucocorticoids. Arthritis Rheum (2007) 1.65
Xenopus tropicalis egg extracts provide insight into scaling of the mitotic spindle. J Cell Biol (2007) 1.63
microRNA-24a is required to repress apoptosis in the developing neural retina. Genes Dev (2009) 1.61
Arx1 functions as an unorthodox nuclear export receptor for the 60S preribosomal subunit. Mol Cell (2007) 1.60
In vivo somatic cell gene transfer of an engineered Noggin mutein prevents BMP4-induced heterotopic ossification. J Bone Joint Surg Am (2003) 1.59
Accelerated gene evolution and subfunctionalization in the pseudotetraploid frog Xenopus laevis. BMC Biol (2007) 1.59
Skeletal overexpression of gremlin impairs bone formation and causes osteopenia. Endocrinology (2004) 1.58
Long-term administration of AMD3100, an antagonist of SDF-1/CXCR4 signaling, alters fracture repair. J Orthop Res (2012) 1.56
Reduced Bone Density and Vertebral Fractures in Smokers. Men and COPD Patients at Increased Risk. Ann Am Thorac Soc (2015) 1.54
The signaling adapter protein DAP12 regulates multinucleation during osteoclast development. J Bone Miner Res (2003) 1.52
Characterization of a Mycobacterium ulcerans-like infection in a colony of African tropical clawed frogs (Xenopus tropicalis). Comp Med (2004) 1.52
Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT. Ann Rheum Dis (2010) 1.51
Neural crest induction by paraxial mesoderm in Xenopus embryos requires FGF signals. Development (2003) 1.49
Patellar cartilage: T2 values and morphologic abnormalities at 3.0-T MR imaging in relation to physical activity in asymptomatic subjects from the osteoarthritis initiative. Radiology (2009) 1.47
Heparan sulfate proteoglycans retain Noggin at the cell surface: a potential mechanism for shaping bone morphogenetic protein gradients. J Biol Chem (2001) 1.43
The longterm outcome of osteoarthritis: rates and predictors of joint space narrowing in symptomatic patients with knee osteoarthritis. J Rheumatol (2002) 1.38
Distinct modes of inhibition by sclerostin on bone morphogenetic protein and Wnt signaling pathways. J Biol Chem (2010) 1.38
Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: a longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice. Arthritis Rheum (2008) 1.36
Very low prevalence of hip osteoarthritis among Chinese elderly in Beijing, China, compared with whites in the United States: the Beijing osteoarthritis study. Arthritis Rheum (2002) 1.36
Actomyosin contractility and microtubules drive apical constriction in Xenopus bottle cells. Dev Biol (2007) 1.33
The effects of impaired joint position sense on the development and progression of pain and structural damage in knee osteoarthritis. Arthritis Rheum (2009) 1.33
Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization. Arthritis Rheum (2008) 1.33
Role of mast cells in acupuncture effect: a pilot study. Explore (NY) (2008) 1.32
Adenovirally expressed noggin and brain-derived neurotrophic factor cooperate to induce new medium spiny neurons from resident progenitor cells in the adult striatal ventricular zone. J Neurosci (2004) 1.30
FGF8 spliceforms mediate early mesoderm and posterior neural tissue formation in Xenopus. Development (2006) 1.29
Glucocorticoid-induced autophagy in osteocytes. J Bone Miner Res (2010) 1.29
Differentiation-dependent secretion of proangiogenic factors by mesenchymal stem cells. PLoS One (2012) 1.29
Comparison of the osteogenic potential of equine mesenchymal stem cells from bone marrow, adipose tissue, umbilical cord blood, and umbilical cord tissue. Am J Vet Res (2010) 1.28
Interpreting mammalian evolution using Fugu genome comparisons. Genomics (2004) 1.26
Angiogenic sprouting into neural tissue requires Gpr124, an orphan G protein-coupled receptor. Proc Natl Acad Sci U S A (2011) 1.26
Association of statin use and development and progression of hip osteoarthritis in elderly women. J Rheumatol (2005) 1.25
MAP kinase and calcium signaling mediate fluid flow-induced human mesenchymal stem cell proliferation. Am J Physiol Cell Physiol (2005) 1.23
Capsaicin-sensitive sensory neurons contribute to the maintenance of trabecular bone integrity. J Bone Miner Res (2004) 1.22
Mitochondrial DNA variant associated with Leber hereditary optic neuropathy and high-altitude Tibetans. Proc Natl Acad Sci U S A (2012) 1.21
Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture. J Bone Miner Res (2003) 1.20
Patterns of compartment involvement in tibiofemoral osteoarthritis in men and women and in whites and African Americans. Arthritis Care Res (Hoboken) (2012) 1.20
Podocyte-derived BMP7 is critical for nephron development. J Am Soc Nephrol (2008) 1.19
Overexpression of secreted frizzled-related protein 1 inhibits bone formation and attenuates parathyroid hormone bone anabolic effects. J Bone Miner Res (2010) 1.19
eShadow: a tool for comparing closely related sequences. Genome Res (2004) 1.18
Relationship between joint shape and the development of osteoarthritis. Curr Opin Rheumatol (2010) 1.17
Hypoxia decreases sclerostin expression and increases Wnt signaling in osteoblasts. J Cell Biochem (2010) 1.17
Effect of transdermal teriparatide administration on bone mineral density in postmenopausal women. J Clin Endocrinol Metab (2009) 1.16
Activation of extracellular-signal regulated kinase (ERK1/2) by fluid shear is Ca(2+)- and ATP-dependent in MC3T3-E1 osteoblasts. Bone (2007) 1.16
Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates. Ann Rheum Dis (2009) 1.15
Sex hormones and frailty in older men: the osteoporotic fractures in men (MrOS) study. J Clin Endocrinol Metab (2009) 1.14
Lumbosacral transitional vertebrae: association with low back pain. Radiology (2012) 1.14
Osteogenesis and trophic factor secretion are influenced by the composition of hydroxyapatite/poly(lactide-co-glycolide) composite scaffolds. Tissue Eng Part A (2010) 1.13
Identification of mutants in inbred Xenopus tropicalis. Mech Dev (2005) 1.13
Conditional deletion of gremlin causes a transient increase in bone formation and bone mass. J Biol Chem (2007) 1.12